166
Views
21
CrossRef citations to date
0
Altmetric
Original Article

Implications of maternal systemic oxidative stress in normal pregnancy and in pregnancy complicated by preeclampsia

, , , , &
Pages 944-951 | Received 16 Feb 2011, Accepted 04 May 2011, Published online: 16 Aug 2011

References

  • Rami N Sammour, Farid M Nakhoul, Andrew P Levy, Rachel Miller–Lotan, Nakhoul Nakoul, Hoda R Awad, Ron Gonen, Gonen Ohel. Haptoglobin phenotipe in women with preeclampsia. Endocrinology 2010;38:303–308.
  • Mehendale S, Kilari A, Dangat K, Tavalekar V, Mahadik S, Joshi S. Fatty acids, antioxidants, and oxidative stress in pre-eclampsia. Int J Gynecol Obstet 2008;100:234–238.
  • Mihu D, Costin N, Mihu CM, Seicean A, Ciortea R. HELLP syndrome - a multisystemic disorder. J Gastrointestin Liver Dis 2007;16:419–424.
  • Imran A Siddiqui, Anila Jaleel, Waleed Tamimi, Hanan M.F Al Kadri. Role of oxidative stress in pathogenesis of preeclampsia. Arch Gynecol Obstet 2010;282:469–474.
  • Guller S. Role of the syncytium in placenta-mediated complications of preeclampsia. Thromb Res 2009;124:389–392.
  • Lorquet S, Pequeux C, Munaut C, Foidart JM. Aetiology and physiopathology of preeclampsia and related forms. Acta Clin Belg 2010;65:237–241.
  • Rani N, Dhingra R, Arya DS, Kalaivani M, Bhatla N, Kumar R. Role of oxidative stress markers and antioxidants in the placenta of preeclamptic patients. J Obstet Gynecol Res 2010;36:1189–1194.
  • Mills TA, Wareing M, Shennan AH, Poston L, Baker PN, Greenwood SL. Acute and chronic modulation of placental chorionic plate artery reactivity by reactive oxygen species. Free Radic Biol Med 2009;47:159–166.
  • Orhan H, Őnderoglu L, Yűcel A, Sahin G. Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet 2003;267:189–195.
  • Patil SB, Kodliwadmath MV, Kodliwadmath M. Lipid peroxidation and antioxidant activity in complicated pregnancies. Clin Exp Obstet Gynecol 2009;36:110–112.
  • Fiore G, Capasso A. Effects of vitamin E and C on placental oxidative stress: an in vitro evidence for the potential therapeutic or prophylactic treatment of preeclampsia. Med Chem 2008;4:526–530.
  • Saker M, Mokhtari NS, Merzouk SA, Merzouk H, Belarbi B, Narce M. Oxidant and antioxidant status in mothers and their newborns according to birthweight. Eur J Obst Gynecol Reprod Biol 2008;141:95–99.
  • Myatt L. Review: reactive oxygen and nitrogen species and functional adoption of the placenta. Placenta 2010;31(suppl.):S 66–S 69.
  • Redman CW, Sargent IL. Pre-eclampsia, the placenta and the maternal systemic inflammatory response–a review. Placenta 2003;24 Suppl A:S21–S27.
  • Burton GJ, Jauniaux E. Oxidative stress: Best practice & Research. Clin Obst Gynaecol 2011; (Epub ahead of print)>.
  • Hung TH, Burton GJ. Hypoxia and reoxygenation: a possible mechanism for placental oxidative stress in preeclampsia. Taiwan J Obstet Gynecol 2006;45:189–200.
  • Karacay O, Sepici–Dincel A, Karcaaltincaba D, Sahin D, Yalva S, Akyol M, Kandemir O, Altan N. A quantitative evaluation of total antioxidant status and oxidative stress markers in preeclampsia and gestational diabetic patients in 24–36 weeks of gestation. Diabetes Res Clin Pract 2010;89:231–238.
  • Kais H, Al-Gubory Paul, A. Fowler, Catherine Garrel. The roles of cellular reactive oxygen species, oxidative stress and antioxidants in pregnancy outcomes. Int J Biochem Cell Biol 2010;42:1634–1650.
  • Burton CJ, Hung TH. Hypoxia—reoxigenation: a potential source of placental oxidative stress in normal pregnancy and preeclampsia. Fetal Matern Med Rev 2003;14:97–117.
  • Kaur G, Mishra S, Sehgal A, Prasad R. Alterations in lipid peroxidation, andandantioxidant status in pregnancy with preeclampsia Mol cell Biochem 2008;313:37–44
  • Bernardi Bernardi F, Guola F, Bortolin T, Petronieho F, Dal–Pizzol F. Oxidative stress and inflammatory markers in normal pregnancy and preeclampsia. J Obstet Gynecol Res 2008;34:948–951.
  • Romero R, Chaiworapongsa T, Espinoza I. Micronutrients and intrauterine infection, preterm birth and the fetal inflammatory response synrdome. J Nutr 2003;133 (5 Suppl. 2):S1668–S1673.
  • Jouniaux E, Poston L, Burton GJ. Placental-related diseases of pregnancy: involument of oxidative stress and implication in human evolution. Hum Reprod Update 2006;12:747–755.
  • Hung JH. Oxidative stress and antioxidants in preeclampsia. J Chin Med Assoc 2007;70:430–432.
  • Cindrova–Davies T. From placental oxidative stress to maternal endothelial dysfunction. Placenta Suppl A 2009;30:S55–S65.
  • Hool LC, Corry B. Redox control of calcium channels: from mechanisms to therapeutic opportunities. Antioxid Redox Signal 2007;9:409–435.
  • Founds SA, Conley YP, Lyons-Weiler JF, Jeyabalan A, Hogge WA, Conrad KP. Altered global gene expression in first trimester placentas of women destined to develop preeclampsia. Placenta 2009;30:15–24.
  • Safronov ID, Trunov AN, Kokareva ED. Prooxidant-antioxidant factors in the blood of pregnant women with late gestosis of different severity. Bull Exp Biol Med 2008;146:800–802.
  • Orhan H, Onderoglu L, Yücel A, Sahin G. Circulating biomarkers of oxidative stress in complicated pregnancies. Arch Gynecol Obstet 2003;267:189–195.
  • Rousseau A, Favier R, Van Dreden P. Elevated circulating soluble thrombomodulin activity, tissue factor activity and circulating procoagulant phospholipids: new and useful markers for pre-eclampsia? Eur J Obstet Gynecol Reprod Biol 2009;146:46–49.
  • Molvarec A, Rigó J Jr, Bõze T, Derzsy Z, Cervenak L, Makó V, Gombos T, et al. Increased plasma von Willebrand factor antigen levels but normal von Willebrand factor cleaving protease (ADAMTS13) activity in preeclampsia. Thromb Haemost 2009;101:305–311.
  • Portelinha A, Belo L, Tejera E, Rebelo I. Adhesion molecules (VCAM-1 and ICAM-1) and C-reactive protein in women with history of preeclampsia. Acta Obstet Gynecol Scand 2008;87:969–971.
  • Molvarec A, Rigo J Jr, Lazar L, Balogh K, Mako V, Cervenak L et al. Increased serum heat −shock protein to levels reflect systemic inflammation, oxidative stress and hepatocellelar injury in preeclampsia. Cell Stress Chaperones 2009;14:151–159.
  • Myatt L, Webster RP. Vascular biology of preeclampsia. J Thromb Haemost 2009;7:375–384.
  • Atamer Y, Koçyigit Y, Yokus B, Atamer A, Erden AC. Lipid peroxidation, antioxidant defense, status of trace metals and leptin levels in preeclampsia. Eur J Obstet Gynecol Reprod Biol 2005;119:60–66.
  • Aydin S, Benian A, Madazli R, Uludag S, Uzun H, Kaya S. Plasma malondialdehyde, superoxide dismutase, sE-selectin, fibronectin, endothelin-1 and nitric oxide levels in women with preeclampsia. Eur J Obstet Gynecol Reprod Biol 2004;113:21–25.
  • Harma M, Harma M, Erel O. Measurement of the total antioxidant response in preeclampsia with a novel automated method. Eur J Obstet Gynecol Reprod Biol 2005;118:47–51.
  • Kaur G, Mishra S, Sehgal A, Prasad R. Alternations in lipid peroxidation and antioxidant status in pregnancy with preeclampsia. Mol Cell Biochem 2008;313:37–44.
  • Anastasakis E, Papantoniou N, Daskalakis G, Mesogitis S, Antsaklis A. Screening for pre-eclampsia by oxidative stress markers and uteroplacental blood flow. J Obstet Gynaecol 2008;28:285–289.
  • Regan CL, Levine RJ, Baird DD, Ewell MG, Martz KL, Sibai BM, Rokach J, et al. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol 2001;185:572–578.
  • Krishna Mohan S, Venkataramana G. Status of lipid peroxidation, glutathione, ascorbic acid, vitamin E and antioxidant enzymes in patients with pregnancy–induced hypertension. Indian J Physiol Pharmacol 2007;51:284–288.
  • Fialová L, Kalousová M, Soukupová J, Malbohan I, Madar J, Frisová V, Stípek S, Zima T. Markers of inflammation in preeclampsia. Prague Med Rep 2004;105:301–310.
  • Zusterzeel PLM, Mulder TPJ, Peters WHM, Wiseman SA, Steergers EAP. Plasma protein carbonyls in nonpregnant, healthy pregnant and preeclamtic women. Free Rad Res 2000;33:471–476.
  • Tsukimori K, Yoshitomi T, Morokuma S, Fukushima K, Wake N. Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am J Hypertens 2008;21:1343–1346.
  • Llurba E, Gratacós E, Martín-Gallán P, Cabero L, Dominguez C. A comprehensive study of oxidative stress and antioxidant status in preeclampsia and normal pregnancy. Free Radic Biol Med 2004;37:557–570.
  • Serdar Z, Gür E, Develioglu O, Colakogullari M, Dirican M. Placental and decidual lipid peroxidation and antioxidant defenses in preeclampsia. Lipid peroxidation in preeclampsia. Pathophysiology 2002;9:21.
  • Regan CL, Levine RJ, Baird DD, Ewell MG, Martz KL, Sibai BM, Rokach J, et al. No evidence for lipid peroxidation in severe preeclampsia. Am J Obstet Gynecol 2001;185:572–578.
  • Roberts JM, Bodnar LM, Lain KY, Hubel CA, Markovic N, Ness RB, Powers RW. Uric acid is as important as proteinuria in identifying fetal risk in women with gestational hypertension. Hypertension 2005;46:1263–1269.
  • Powers RW, Bodnar LM, Ness RB, Cooper KM, Gallaher MJ, Frank MP, Daftary AR, Roberts JM. Uric acid concentrations in early pregnancy among preeclamptic women with gestational hyperuricemia at delivery. Am J Obstet Gynecol 2006;194:160.
  • Many A, Hubel CA, Roberts JM. Hyperuricemia and xanthine oxidase in preeclampsia, revisited. Am J Obstet Gynecol 1996;174:288–291.
  • Lam C, Lim KH, Kang DH, Karumanchi SA. Uric acid and preeclampsia. Semin Nephrol 2005;25:56–60.
  • Bainbridge SA, Roberts JM. Uric acid as a pathogenic factor in preeclampsia. Placenta 2008;29 Suppl A:S67–S72.
  • Tsukimori K, Yoshitomi T, Mokokuma S, Fukushima K, Wake N. Serum uric acid levels correlate with plasma hydrogen peroxide and protein carbonyl levels in preeclampsia. Am J Hypertens 2008;21:1343–1346.
  • Karowicz–Bilinska A, Edziora K–, Kornatowska K, Bartosz G. Indices of oxidative stress in pregnancy with fetal growth restriction. Free Rad Res 2007;1:870–873.
  • Takagi Y, Nikaido T, Toki T, Kita N, Kanai M, Ashida T, Ohira S, Konishi I. Levels of oxidative stress and redox-related molecules in the placenta in preeclampsia and fetal growth restriction. Virchows Arch 2004;444:49–55.
  • Roberts JM, Myatt L, Spong CY, Thom EA, Hauth JC, Leveno KJ, Pearson GD, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med 2010;362:1282–1291.
  • Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, Julien P, Smith G, et al.; INTAPP study group. An international trial of antioxidants in the prevention of preeclampsia (INTAPP). Am J Obstet Gynecol 2010;202:239.e1–239.e10.
  • Catov JM, Nohr EA, Bodnar LM, Knudson VK, Olsen SF, Olsen J. Association of periconceptional multivitamin use with reduced risk of preeclampsia among normal-weight women in the Danish National Birth Cohort. Am J Epidemiol 2009;169:1304–1311.
  • Klemmensen A, Tabor A, Østerdal ML, Knudsen VK, Halldorsson TI, Mikkelsen TB, Olsen SF. Intake of vitamin C and E in pregnancy and risk of pre-eclampsia: prospective study among 57 346 women. BJOG 2009;116:964–974.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.